Erectile dysfunction: a global review of intracavernosal injectables.
Catriona DuncanGhadir J OmranJiasian TehNiall F DavisDamien M BoltonNathan L LawrentschukPublished in: World journal of urology (2019)
ICIs are associated with good clinical efficacy rates, high discontinuation rates and a moderate side-effect profile. They represent an important tool in the urological armamentarium for treating ED in patients that cannot tolerate or are refractory to oral therapies.